Archives
Pressure to succeed has only increased since Kansas City-based Mobility Designed found its footing as the first new design for crutches since the Civil War, said co-founders Max and Liliana Younger.
What began as a personal mission to develop a more comfortable crutch has evolved into a successful startup with ever-increasing aspirations. The company is now in the middle of its second round of funding and poised to release a new product by the end of summer.
April 29, 2019
Biomedical Devices of Kansas Selects New President
Biomedical Devices of Kansas today announced that Keith Baird has been selected as the new President of Biomedical Devices of Kansas. Baird succeeds Bill Graveman, who will assume the role of CEO of Biomedical Devices of Kansas. Graveman will also continue his responsibilities as Vice President of Engineering and Development for Novian Health.
Mobility Designed developed an innovative forearm crutch that allows users to support their weight via their forearms and have use of their hands to do everyday tasks. For a number of users, the design creates a painless experience compared with traditional underarm crutches.
Doctor’s at University of Kansas Health System are using new groundbreaking medical technology that is changing lives.
June 27, 2017
Mobility Designed Names New CEO, Raises More Than $1M
Mobility Designed, a Kansas City medical device startup, has appointed a new CEO. Previously held by co-founder Liliana Younger, the CEO role is now held by Dan Alcazar. A serial entrepreneur, Alcazar has experience growing early-stage, mid-sized and Fortune 500 companies, including RJR Nabisco, Sprint and Embarq. Younger will remain on the board and maintain an active role within the Mobility Designed. Full Story »
March 30, 2015
Digital Sandbox KC backed with “Unprecedented” Second Grant
Digital Sandbox KC, a project funding source for startup businesses, has gained $1.15 million in backing partly through a federal grant.
September 25, 2014
Nova StatStrip Glucose Hospital Meter System Receives FDA Clearance for Intensive Care Use
Nova Biomedical’s StatStrip Glucose Hospital Meter System is the first blood glucose monitoring system to receive clearance from the U.S. Food and Drug Administration (FDA) for use throughout all hospital and all professional healthcare settings, including intensive care settings.
Contact the Medical Device Network with any inquiries.
Please register to stay informed on the latest Medical Device Network and regional life science news and events.
